292 related articles for article (PubMed ID: 26911282)
1. Cervical cancer: A comprehensive approach towards extermination.
Bava SV; Thulasidasan AK; Sreekanth CN; Anto RJ
Ann Med; 2016; 48(3):149-61. PubMed ID: 26911282
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
5. [Perspective of cervical cancer prevention and control in developing countries and areas].
Qiao YL
Chin J Cancer; 2010 Jan; 29(1):1-3. PubMed ID: 20038301
[TBL] [Abstract][Full Text] [Related]
6. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of human papillomavirus genotyping.
Choi YJ; Park JS
J Gynecol Oncol; 2016 Mar; 27(2):e21. PubMed ID: 26768784
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria.
Nejo YT; Olaleye DO; Odaibo GN
PLoS One; 2019; 14(11):e0224748. PubMed ID: 31682636
[TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus (HPV) molecular diagnostics.
Kroupis C; Vourlidis N
Clin Chem Lab Med; 2011 Nov; 49(11):1783-99. PubMed ID: 21875401
[TBL] [Abstract][Full Text] [Related]
10. Strategies against human papillomavirus infection and cervical cancer.
Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
[TBL] [Abstract][Full Text] [Related]
11. Role of human papilloma virus testing in cervical cancer prevention.
Fey MC; Beal MW
J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
13. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
Dillner L; Pagliusi S; Bray F; Lorincz A; Kjaer SK; Anttila A; Iversen OE; Dillner J; Lehtinen M; Paavonen J
Acta Obstet Gynecol Scand; 2008; 87(5):489-98. PubMed ID: 18446530
[TBL] [Abstract][Full Text] [Related]
14. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
16. Prospects for a prophylactic HPV vaccine: rationale and future implications for cervical cancer screening.
Sherman ME; Schiffman MH; Strickler H; Hildesheim A
Diagn Cytopathol; 1998 Jan; 18(1):5-9. PubMed ID: 9451552
[TBL] [Abstract][Full Text] [Related]
17. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
Wheeler CM
Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
[No Abstract] [Full Text] [Related]
18. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
[TBL] [Abstract][Full Text] [Related]
19. [Advances in Understanding Carcinogenetic Mechanisms of the Human Papillomavirus and Vaccines Based on Virus-like Particles].
Zhao Z; Wang L; Ma B
Bing Du Xue Bao; 2015 Mar; 31(2):180-6. PubMed ID: 26164945
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
